Your trusted source for investing success

Tag: Google

Tech Forecast and Promising Tech Stocks To Buy in 2017

Learn about breakthrough technology about to impact lives around the globe. We cover the entire industry in our FREE investor’s report.   Gain Access
Global Cannabis Applications Announces CannaLife App on Google Play

Global Cannabis Applications Announces CannaLife App on Google Play

Global Cannabis Applications Corp (GCAC) (CSE:APP, FRA:2FA, OTCQB:FUAPF), a leading developer of innovative data technologies for the cannabis industry, is pleased to announce the submission of the CannaLifeapp to the Google Play Store.

CannaLife Social Engagement App for Medical Cannabis

Targeted towards both active and non-active medical cannabis users, CannaLife was designed to

4 Mobile Video Game Stocks

4 Mobile Video Game Stocks

The mobile video game sector is poised to account for nearly half of the overall video game industry by 2020. Here’s a look at 4 mobile video game stocks with market caps of less than $500 million for investor consideration.

Data Investment Facts

Data Investment Facts

The data market is vast and can be somewhat complicated. In that regard, here is a brief overview of data investment facts for those looking to jump into the sector.

Vitality Biopharma Achieves Cannabinoid Pharmaceutical Biosynthesis Breakthrough

Vitality Biopharma (OTCQB:VBIO) has announced it has achieved a biosynthesis breakthrough.

As quoted in the press release:
Vitality has developed a proprietary biosynthesis technology that can modify cannabinoids in order to create pharmaceutical prodrugs that have no psychoactivity and that are able to provide targeted disease treatment. This process involves small molecule glycosylation,

DelMar Pharmaceuticals Presents Poster at AACR’s Ovarian Cancer Special Conference on the Mechanistic Rationale for VAL-083 Overcoming Treatment Resistance in Ovarian Cancer

DelMar Pharmaceuticals Presents Poster at AACR’s Ovarian Cancer Special Conference on the Mechanistic Rationale for VAL-083 Overcoming Treatment Resistance in Ovarian Cancer

DelMar Pharmaceuticals, Inc. (NASDAQ: DMPI), a biopharmaceutical company focused on the development of new cancer therapies, today announced the presentation of a poster at the American Association for Cancer Research (AACR) Special Conference: Addressing Critical Questions in Ovarian Cancer Research and Treatment, being held October 1-4, 2017 in Pittsburgh, PA.  The poster entitled “Distinct mechanism of

DelMar Pharmaceuticals Announces Fiscal Year 2017 Financial Results

DelMar Pharmaceuticals Announces Fiscal Year 2017 Financial Results

DelMar Pharmaceuticals, Inc. (NASDAQ: DMPI), a biopharmaceutical company focused on the development and commercialization of new cancer therapies, announced its financial results for the year ended June 30, 2017.   DelMar executive management will host a business update conference call and live webcast for investors, analysts and other interested parties on Wednesday, October 4, 2017 at 4:30

DelMar Pharmaceuticals to Present at AACR Special Conference on Ovarian Cancer

DelMar Pharmaceuticals to Present at AACR Special Conference on Ovarian Cancer

 DelMar Pharmaceuticals, Inc. (NASDAQ: DMPI), a biopharmaceutical company focused on the development of new cancer therapies, today announced that it will be presenting an abstract at the American Association for Cancer Research (AACR) Special Conference: Addressing Critical Questions in Ovarian Cancer Research and Treatment, being held on October 1-4, 2017 in Pittsburgh, PA at the Wyndham Grand.

DelMar

Tech Stocks Slide on North Korea Comments

Tech Stocks Slide on North Korea Comments

North Korea’s foreign minister said on Monday that US President Trump’s comments over the weekend are a declaration of war. Following that, the tech-heavy NASDAQ Composite Index dropped nearly 1 percent.

Tech Forecast and Promising Tech Stocks To Buy in 2017

Learn about breakthrough technology about to impact lives around the globe. We cover the entire industry in our FREE investor’s report.   Gain Access
Enter Your Log In Credentials
This setting should only be used on your home or work computer.

×

Privacy & Legal Policy

Privacy Policy

×
Investing News Network

Send this to a friend

Hi,
I thought you might find this interesting:
Microsoft and Amazon Partner Up on AI Software, Gluon

URL: https://investingnews.com/daily/tech-investing/data-investing/microsoft-and-amazon-partner-up-on-ai-software-gluon/